PRITOR

This brand name is authorized in Austria, Estonia, France, Ireland, Italy, Lithuania, Poland, South Africa, Spain.

Active ingredients

The drug PRITOR contains one active pharmaceutical ingredient (API):

1	Telmisartan UNII U5SYW473RQ - TELMISARTAN
	Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
	Read more about Telmisartan

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA07	Telmisartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1011485, 1060524, 1060614, 1060625, 1060636, 1183519, 1226326, 1226337, 1226348, 1241042, 1241053, 1241064, 1241075, 1241086, 1241097, 1241109, 1241110, 1286029, 1286030, 1286041
ES	Centro de información online de medicamentos de la AEMPS	98089002, 98089007, 98089007IP, 98089007IP1, 98089007IP2, 98089007IP3, 98089007IP4, 98089012
FR	Base de données publique des médicaments	60560224, 61842988, 68369993
IT	Agenzia del Farmaco	034326025, 034326076, 034326126
LT	Valstybinė vaistų kontrolės tarnyba	1004321, 1004322, 1013482, 1013483, 1013484, 1013487, 1013488, 1013489, 1013490, 1013491, 1015556, 1030407, 1030408, 1030409, 1030410, 1030411, 1030412, 1030413, 1030414, 1030415, 1030416, 1030417
PL	Rejestru Produktów Leczniczych	100091637, 100091643, 100112279
ZA	Health Products Regulatory Authority	33/7.1.3/0022, 33/7.1.3/0023